Nuclear processes such as transcription, DNA replication and recombination are dynamically regulated by chromatin structure. Eukaryotic transcription is known to be regulated by chromatinassociated proteins containing conserved protein domains that specifically recognize distinct covalent post-translational modifications on histones. However, it has been unclear whether similar mechanisms are involved in mammalian DNA recombination. Here we show that RAG2-an essential component of the RAG1/2 V(D)J recombinase, which mediates antigen-receptor gene assembly 1 -contains a plant homeodomain (PHD) finger that specifically recognizes histone H3 trimethylated at lysine 4 (H3K4me3). The high-resolution crystal structure of the mouse RAG2 PHD finger bound to H3K4me3 reveals the molecular basis of H3K4me3-recognition by RAG2. Mutations that abrogate RAG2's recognition of H3K4me3 severely impair V(D)J recombination in vivo. Reducing the level of H3K4me3 similarly leads to a decrease in V(D)J recombination in vivo. Notably, a conserved tryptophan residue (W453) that constitutes a key structural component of the K4me3-binding surface and is essential for RAG2's recognition of H3K4me3 is mutated in patients with immunodeficiency syndromes. Together, our results identify a new function for histone methylation in mammalian DNA recombination. Furthermore, our results provide the first evidence indicating that disrupting the read-out of histone modifications can cause an inherited human disease.
Nuclear processes such as transcription, DNA replication and recombination are dynamically regulated by chromatin structure. Eukaryotic transcription is known to be regulated by chromatinassociated proteins containing conserved protein domains that specifically recognize distinct covalent post-translational modifications on histones. However, it has been unclear whether similar mechanisms are involved in mammalian DNA recombination. Here we show that RAG2-an essential component of the RAG1/2 V(D)J recombinase, which mediates antigen-receptor gene assembly 1 -contains a plant homeodomain (PHD) finger that specifically recognizes histone H3 trimethylated at lysine 4 (H3K4me3). The high-resolution crystal structure of the mouse RAG2 PHD finger bound to H3K4me3 reveals the molecular basis of H3K4me3-recognition by RAG2. Mutations that abrogate RAG2's recognition of H3K4me3 severely impair V(D)J recombination in vivo. Reducing the level of H3K4me3 similarly leads to a decrease in V(D)J recombination in vivo. Notably, a conserved tryptophan residue (W453) that constitutes a key structural component of the K4me3-binding surface and is essential for RAG2's recognition of H3K4me3 is mutated in patients with immunodeficiency syndromes. Together, our results identify a new function for histone methylation in mammalian DNA recombination. Furthermore, our results provide the first evidence indicating that disrupting the read-out of histone modifications can cause an inherited human disease.
Many studies suggest that V(D)J recombination is regulated by modulating the chromatin structure of antigen-receptor loci during lymphoid development 2 . Several studies have analysed the pattern of histone modifications present at the immunoglobulin heavy chain locus during B-cell development [3] [4] [5] . However, mechanisms linking histone modifications to the function of the RAG recombinase have remained elusive.
Because RAG2 contains a non-canonical plant homeodomain (PHD) finger 6, 7 -a module that can mediate interactions with chromatin 8-10 -we asked whether a polypeptide encompassing the RAG2 PHD finger (RAG2 PHD ; amino acids 414-527) can recognize modified histone proteins. In an in vitro screen of peptide microarrays containing ,70 distinct modified histone peptides, we found that RAG2 PHD specifically binds to histone H3 trimethylated at lysine 4 (H3K4me3) (Fig. 1a, Supplementary Fig. 1 , and data not shown). The specificity of this interaction was confirmed by peptide pulldown assays (Fig. 1b, Supplementary Fig. 2 and Supplementary  Fig. 3 ). RAG2 has a carboxy-terminal extension of 40 amino acids that is essential for phosphoinositide (PtdIns)-binding 7 (amino acids 488-527), but this region is dispensable for H3K4me3-binding because the minimal PHD finger alone (amino acids 414-487) is sufficient for H3K4me3-recognition (Fig. 1c) . In addition, the acidic hinge region of RAG2 (amino acids 388-412), previously implicated in histone-binding 11 , is dispensable for recognition of H3K4me3 (Fig. 1d) . Moreover, mutations in the acidic hinge region, which had previously been shown to interfere with histone binding 11 , had no effect on the H3K4me3 interaction (Fig. 1d) . Using calf thymus histone protein pull-down assays, we confirmed that the interaction between RAG2 PHD and H3K4me3 occurs in the context of full-length histone proteins (Fig. 1e) . Furthermore, RAG2 PHD bound to native mononucleosomes purified from HeLa cells, but not to mononucleosomes reconstituted from bacterially expressed recombinant histones, indicating that the RAG2 PHD -nucleosome interaction is dependent on post-translational histone modifications (Fig. 1f) . Although full-length RAG2 binds H3K4me3 peptides, core RAG2 (amino acids 1-387)-the minimal portion of RAG2 required for V(D)J cleavage in vitro-which lacks the PHD finger, does not (Fig. 1g) . Consistent with the pull-down results, tryptophan fluorescence measurements using RAG2 PHD determined dissociation constants (K d ) of ,4 mM for H3K4me3, ,60 mM for H3K4me2, ,120 mM for H3K4me1 and ,500 mM for H3K4me0 (Supplementary Fig. 5 ). Thus, the RAG2 PHD finger is a chromatin-binding module that recognizes H3K4me3.
To understand the molecular basis of the interaction between the RAG2 PHD finger and H3K4me3, we determined the crystal structure of the RAG2 PHD -H3K4me3 complex at 1.15 Å resolution (Fig. 2, Supplementary Fig. 6 and Supplementary Table 1 ). In three previously published PHD-H3K4me3 structures [12] [13] [14] , the H3 peptide extends straight through the peptide-binding groove. However, in the RAG2 PHD -H3K4me3 structure, the H3 peptide is kinked by ,90u at Q5. The K4me3 side chain is recognized by cation-p interactions within an aromatic channel delimited by Y415 on the left, M443 on the back and W453 on the right (Fig. 2a) . Despite not revealing any primary sequence conservation with the K4me3-binding residues of ING2, BPTF and YNG1 ( Supplementary  Fig. 7 ), RAG2 forms a similar K4me3-binding pocket (Fig. 2c) . Interestingly, RAG2 PHD lacks the canonical 'aromatic cage' often employed to bind trimethylated lysine residues 15 ( Fig. 2b, c) . Instead of being closed on both sides, the back and the top (as observed with other PHD fingers [12] [13] [14] , the RAG2 PHD K4me3-binding surface is open on the top, and resembles an 'aromatic channel' rather than an 'aromatic cage' (Fig. 2b, c) . This 'channel' conformation may provide a mechanism to modulate histone binding 16 . Aside from the K4me3 and Q5 residues, the remaining side chains of H3 form no specific interactions with RAG2 PHD . Finally, unlike other H3K4me3-binding PHD fingers 9, [12] [13] [14] 17 , RAG2 PHD does not have acidic residues (Asp or Glu) positioned to electrostatically interact with H3R2 (ref. 16) (Fig. 2c) .
The three residues in RAG2 that form the aromatic channel critical for trimethyl-lysine recognition are completely conserved through evolution ( Supplementary Fig. 8 ). As expected, mutating any one of these residues (Y415A, M443A, W453A/R) abrogated H3K4me3-binding by RAG2 PHD (Fig. 3a) and by full-length RAG2 (Fig. 3b) . Because the W453R mutation has been implicated in the pathogenesis of Omenn's syndrome 18 -a rare severe combined immunodeficiency 19 and the molecular mechanism linking this mutation to Omenn's syndrome remains unknown 7 , we further characterized W453R's role in histone binding. Consistent with the critical role of this residue in forming the recognition surface for H3K4me3, introducing this mutation into the RAG2 PHD finger (RAG2 PHD-W453R ) abolished the ability of RAG2 PHD to bind either full-length histone H3 (Fig. 3c ) or intact nucleosomes (Fig. 3d) . Thus, the interaction of RAG2 with histone proteins in vitro is dependent on H3K4me3-binding. We note that RAG2 PHD-W453R is properly folded, as indicated by a comparison of the 1 H- 15 N heteronuclear single quantum correlation spectra of RAG2 PHD and RAG2 PHD-W453R ( Supplementary Fig. 9 ). In addition, the Y415A and M443A substitutions had no effect on PtdIns-binding by RAG2 PHD (Supplementary Fig. 10 ), and W453R-associated recombination defects were previously demonstrated to be independent of the PtdIns-binding activity of RAG2 (ref. 7) . Thus, the identification of multiple different point mutations that selectively abrogate RAG2's recognition of H3K4me3 allowed us to study the functional significance of this interaction.
Before analysing the effect of H3 methylation on V(D)J recombination in vivo, we first wanted to confirm that RAG2 Y415A , RAG2 M443A and RAG2 W453R disrupt H3K4me3-binding without affecting protein folding or the inherent catalytic properties of RAG2. We tested the ability of recombinant wild-type and mutant RAG2 proteins to catalyse V(D)J cleavage in vitro on a naked DNA substrate. In these assays, the recombinant proteins, which all expressed and purified equally well (Fig. 3e ), were incubated with core RAG1 (amino acids 38421008), and a DNA substrate. All three H3K4me3-binding mutants catalysed V(D)J cleavage at wildtype levels (Fig. 3f) . Therefore, the H3K4me3-binding mutants-RAG2 Y415A , RAG2 M443A and RAG2 W453R -are properly folded and catalytically active and, thus, can be used for in vivo functional analyses.
Next, to address whether the recognition of methylated H3 by RAG2 PHD has a role in regulating RAG2 function in vivo, we performed extrachromosomal V(D)J recombination assays with the H3K4me3-binding mutants. Fibroblast cell lines were transfected with an exogenous recombination substrate that becomes partially chromatinized when introduced into cells and that has nucleosomes positioned over the recombination signal sequences 20 , along with full-length RAG1, and either full-length wild-type RAG2, RAG2 Y415A , RAG2 M443A , or RAG2 W453R . Strikingly, despite being expressed at comparable levels to wild-type RAG2 (Fig. 4a , western blot), all three H3K4me3-binding mutants exhibited a profound decrease (.90%) in recombination activity (Fig. 4a, graph) . Thus, the H3K4me3-recognition activity of RAG2 is required for V(D)J recombination in vivo.
To test directly the importance of H3K4 methylation and the interaction between RAG2 and H3K4me3 for V(D)J recombination in vivo, we used two different methods to reduce endogenous H3K4 methylation levels, and then repeated the extrachromosomal V(D)J recombination assays. First, H3K4 methylation levels were reduced (Fig. 4b, western Free nuc.
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HeLa nucleosomes Recombinant nucleosomes Supplementary Fig. 4 (Fig. 4b, table and right graph) , indicating that the reduction observed for wild-type RAG2 is specifically due to reduced H3K4me3 binding. In a second independent method, we reduced H3K4me3 levels by transiently expressing the H3K4me3 demethylase SMCX (also known as JARID1C) 22 . As with WDR5 shRNA, we observed that decreases in H3K4me3 levels (Fig. 4c, western blot) resulted in a significant reduction in recombination (,45%) in cells expressing SMCX (Fig. 4c, table and left graph) . V(D)J recombination by RAG2 W453R was unaffected by SMCX expression (Fig. 4c,  table and right graph) . Thus, reducing either the levels of H3K4 methylation or the ability of RAG2 to bind H3K4me3, impairs V(D)J recombination.
Because H3K4me3 is observed at actively rearranging gene segments 23 ( Supplementary Fig. 12 ), we assayed the ability of the H3K4me3-binding mutants to perform chromosomal V(D)J recombination at the endogenous murine IgH locus. RAG2 2/2 Pro-B cells were transduced with lentiviruses encoding either RAG2, RAG2 Y415A , RAG2 M443A or RAG2 W453R and the extent of D H -to-J H recombination in the transduced cell populations was measured using a standard semi-quantitative PCR strategy. Despite being expressed at comparable levels to wild-type RAG2 (Fig. 4d, left panel) , all three H3K4me3-binding mutants exhibited a dramatic reduction in D Hto-J H recombination (Fig. 4d, right panel) . Thus, we conclude that recognition of H3K4me3 by RAG2 PHD is crucial for V(D)J recombination at the endogenous immunoglobulin locus.
Our findings provide the first direct molecular link between histone methylation and mammalian DNA recombination. Before this study, H3K4me3 had only been demonstrated to function in the regulation of gene expression 15 . Our results, demonstrating a novel function for this mark in V(D)J recombination, highlight that chromatin structure can be coupled to diverse nuclear processes by protein modules that recognize modified histones. We have also provided the first evidence that disrupting the read-out of histone modifications can cause an inherited human disease. Omenn's syndrome has been observed in patients carrying a W453R mutation in RAG2 (ref. 18 ). Because RAG2 W453R exhibits wild-type enzymatic activity in vitro 7 ( Fig. 3f) , it has been unclear how this mutation causes immunodeficiency. Here we have shown that the W453R mutation disrupts the read-out of H3K4me3, thereby providing a molecular explanation of how RAG2 W453R causes Omenn's syndrome. Although the W453R, M443A, and Y415A point mutations-which selectively disrupt H3K4me3-recognition-severely disrupt V(D)J recombination, complete deletion of the RAG2 C terminus (including the PHD finger) only partially compromises V(D)J recombination activity [24] [25] [26] [27] ( Supplementary Fig. 11 ). We propose that the RAG2-H3K4me3 interaction serves two functions: (1) increases the stable association of RAG1/2 complexes at target sites and (2) might relieve an inhibitory activity present in the C-terminal portion of RAG2 (ref. 7) (Supplementary Fig. 13 ). Taken together with other studies that have demonstrated a link between the writing of histone modifications and human disease 15, 28, 29 , our results highlight the fundamental role chromatin has in human health. We postulate that, in the coming years, other naturally occurring mutations that cause inherited human diseases will be linked to disruption of lysine methylation signalling pathways. Note added in proof: While this work was under review, another study also reported that the RAG2 PHD finger binds to methylated H3K4 (ref. 30) .
METHODS SUMMARY
Biotinylated peptides were synthesized at Stanford or Yale Protein and Nucleic Acid facilities. Peptide microarray experiments were performed essentially as described 17 . Biotinylated peptide pull-down assays, calf thymus histone binding assays, and mononucleosome gel-shift assays were performed as 9 . Tryptophan fluorescence assays were performed essentially as described 13 . Nuclear magnetic resonance (NMR) structure determination was performed as described 7 . The structure determination is described in Methods. In vitro V(D)J cleavage assays were performed as described 31 . The extrachromsomal V(D)J recombination assays and the endogenous V(D)J recombination assay are described in Methods. Information about antibodies is available in Methods.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
